RestoreX Traction Kit
RestoreX Penile Traction Therapy Device for the treatment of Peyronie’s disease or restoring lost penile length
RestoreX was developed in cooperation with Mayo Clinic and was invented by a board-certified Urologist specializing in Men’s Sexual Health. RestoreX treats Peyronie’s disease as well as lost penile length resulting from urological surgeries and treatments or chronic disease.
- To correct penile curvature or indentation/hourglass deformity
- To restore penile length loss occurring from medical conditions or due to prior surgery or trauma
- To limit loss of erectile function post-prostatectomy
- Easy to use: 2 x 30 minute sessions at home per day
- FSA/HSA eligible with prescription
- 12-month limited-warranty
- Shipped in discreet packaging
Please note that the RestoreX device accommodates stretched penile length of 3.75 to 10 inches.
No returns are allowed. RestoreX is a medical device, used on the body, that cannot be cleaned or re-sold and is considered a biohazard and medical waste. All sales are final.
Additional Information
Curve Improvement
- 77% experienced curve improvement
- Of whom, 28% average improvement
- Durable results after stopping therapy
Clinical Results
- Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial - PubMed (nih.gov)
- Outcomes of RestoreX Penile Traction Therapy in Men With Peyronie's Disease: Results From Open Label and Follow-up Phases - PubMed (nih.gov)
Penile Length Improvement
- Peyronie’s disease: +1.6 cm (3 months)
- Peyronie’s disease: +2.0 cm (6 months)
- Post-prostatectomy: +1.6 cm (5 months)
- Post-prostatectomy: +1.8 cm (8 months)
Clinical Results
- Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial - PubMed (nih.gov)
- Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial - PubMed (nih.gov)
- Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial - PubMed (nih.gov)